Department of Oncology

Selected research products

Casadei-Gardini A, Leone F, Brandi G, Scartozzi M, Silvestris N, Santini D, Faloppi L, Aglietta M, Satolli MA, Rizzo A, Lonardi S, Aprile G, Fornaro L. (2023) Survival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in Italy. Frontiers in oncology 13 1128930 [DOI  PMID]

Parisi A, Giampieri R, Mammarella A, Felicetti C, Salvatore L, Bensi M, Maratta MG, Strippoli A, Filippi R, Satolli MA, Petrillo A, Daniele B, De Tursi M, Di Marino P, Giordano G, Landriscina M, Vitale P, Zurlo IV, Dell'Aquila E, Tomao S, Depetris I, Di Pietro FR, Zoratto F, Ciardiello D, Pensieri MV, Garrone O, Galassi B, Ferri C, Berardi R, Ghidini M. (2022) Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis. Frontiers in oncology 12 935826 [DOI  PMID]

Rimini M, Casadei-Gardini A, Brandi G, Leone F, Fornaro L, Pella N, Silvestris N, Montagnani F, Lonardi S, Lai E, Galizia E, Santini D, Palloni A, Filippi R, Masi G, Aprile G, Aglietta M, Frega G, Fenocchio E, Vivaldi C, Satolli MA, Salani F, Scartozzi M, Faloppi L, Pellino A, Sperti E, Burgio V, Ratti F, Aldrighetti L, Cascinu S, Cucchetti A. (2022) Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy. Journal of chemotherapy (Florence, Italy) 34(8) 543-549 [DOI  PMID]

Giommoni E, Lavacchi D, Tirino G, Fornaro L, Iachetta F, Pozzo C, Satolli MA, Spallanzani A, Puzzoni M, Stragliotto S, Sisani M, Formica V, Giovanardi F, Strippoli A, Prisciandaro M, Di Donato S, Pompella L, Pecora I, Romagnani A, Fancelli S, Brugia M, Pillozzi S, De Vita F, Antonuzzo L. (2021) Results of the observational prospective RealFLOT study. BMC cancer 21(1) 1086 [DOI  PMID]

Filippi R, Leone F, Fornaro L, Aprile G, Casadei-Gardini A, Silvestris N, Palloni A, Satolli MA, Scartozzi M, Russano M, Lutrino SE, Lombardi P, Frega G, Garattini SK, Vivaldi C, Spadi R, Giulia O, Fenocchio E, Brunetti O, Aglietta M, Brandi G. (2022) Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis. Journal of chemotherapy (Florence, Italy) 34(2) 123-132 [DOI  PMID]

Filippi R, Montagnani F, Lombardi P, Fornaro L, Aprile G, Casadei-Gardini A, Faloppi L, Palloni A, Satolli MA, Scartozzi M, Citarella F, Lutrino SE, Vivaldi C, Silvestris N, Rovesti G, Rimini M, Aglietta M, Brandi G, Leone F. (2021) A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy. Acta oncologica (Stockholm, Sweden) 60(10) 1317-1324 [DOI  PMID]

Filippi R, Depetris I, Satolli MA. (2021) Evaluating larotrectinib for the treatment of advanced solid tumors harboring an NTRK gene fusion. Expert opinion on pharmacotherapy 22(6) 677-684 [DOI  PMID]

Mucciolo G, Curcio C, Roux C, Li WY, Capello M, Curto R, Chiarle R, Giordano D, Satolli MA, Lawlor R, Scarpa A, Lukac P, Stakheev D, Provero P, Vannucci L, Mak TW, Novelli F, Cappello P. (2021) IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions. Proceedings of the National Academy of Sciences of the United States of America 118(6) [DOI  PMID]

Mandili G, Curcio C, Bulfamante S, Follia L, Ferrero G, Mazza E, Principe M, Cordero F, Satolli MA, Spadi R, Evangelista A, Giordano D, Viet D, Cappello P, Novelli F. (2020) In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination. Journal for immunotherapy of cancer 8(2) [DOI  PMID]

Mandili G, Follia L, Ferrero G, Katayama H, Hong W, Momin AA, Capello M, Giordano D, Spadi R, Satolli MA, Evangelista A, Hanash SM, Cordero F, Novelli F. (2020) Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients. Cancers 12(3) [DOI  PMID]

Courses

• INFERMIERISTICA CLINICA DELL'AREA DELLA CRONICITA', DELLA DISABILITA' E DELLE CURE PALLIATIVE - D.M. 270/04 (MED3054)
  Corso di Laurea in Infermieristica - Sede TO4 Ivrea
• Oncologia medica (SSFO) - anno solare 2022/2023 (STF0186)
  Corsi di studio in
  Farmacia - Chimica e tecnologia farmaceutiche
• Oncologia medica e cure palliative - D.M. 270/04 (MED3054D)
  Corso di Laurea in Infermieristica - Sede TO4 Ivrea

Scuola di Specializzazione Ginecologia ed ostetricia

Scuola di Specializzazione in Chirurgia

Scuola di Specializzazione in Farmacologia ospedaliera

Scuola di Specializzazione in Medicina di urgenza

Master II livello Pathways ginecological oncology

Master I livello Posizionamento sistemi venosi centrali

Research topics

Clinical research in upperGI cancers

Activities in agenda

See my calendar

Academic bodies

• Department Council - Department of Oncology

• Consiglio di Dipartimento - Dipartimento di Oncologia

Office hours